Download
00234_2024_Article_3384.pdf 1,70MB
WeightNameValue
1000 Titel
  • Imaging in malignant germ cell tumors involving the hypothalamo-neurohypophyseal axis: the evaluation of the posterior pituitary bright spot is essential
1000 Autor/in
  1. Quenzer, Annika |
  2. Calaminus, Gabriele |
  3. Weisthoff, Mathilda Catherine |
  4. Serfling, Julia |
  5. Pietsch, Torsten |
  6. Bison, Brigitte |
  7. Pham, Mirko |
  8. Warmuth-Metz, Monika |
1000 Verlag
  • Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-06-07
1000 Erschienen in
1000 Quellenangabe
  • 66(8):1405-1416
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00234-024-03384-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11246258/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>Malignant intracranial germ cell tumors (GCTs) are rare diseases in Western countries. They arise in midline structures and diagnosis is often delayed. We evaluated imaging characteristics and early tumor signs of suprasellar and bifocal GCT on MRI.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Patients with the diagnosis of a germinoma or non-germinomatous GCT (NGGCT) who received non-contrast sagittal T1WI on MRI pre-therapy were included. Loss of the posterior pituitary bright spot (PPBS), the expansion and size of the tumor, and the expansion and infiltration of surrounding structures were evaluated. Group comparison for histologies and localizations was performed.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>A total of 102 GCT patients (median age at diagnosis 12.3 years, range 4.4–33.8; 57 males; 67 in suprasellar localization) were enrolled in the study. In the suprasellar cohort, NGGCTs (<jats:italic>n</jats:italic> = 20) were noticeably larger than germinomas (<jats:italic>n</jats:italic> = 47; <jats:italic>p</jats:italic> &lt; .001). Each tumor showed involvement of the posterior lobe or pituitary stalk. A PPBS loss (total <jats:italic>n</jats:italic> = 98) was observed for each localization and entity in more than 90% and was related to diabetes insipidus. Osseous infiltration was observed exclusively in suprasellar GCT (significantly more frequent in NGGCT; <jats:italic>p</jats:italic> = .004). Time between the first MRI and therapy start was significantly longer in the suprasellar cohort (<jats:italic>p</jats:italic> = .005), with an even greater delay in germinoma compared to NGGCT (<jats:italic>p</jats:italic> = .002). The longest interval to treatment had circumscribed suprasellar germinomas (median 312 days).</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>A loss of the PPBS is a hint of tumor origin revealing small tumors in the neurohypophysis. Using this sign in children with diabetes insipidus avoids a delay in diagnosis.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Pituitary Gland, Posterior/diagnostic imaging [MeSH]
lokal Pituitary Neoplasms/diagnostic imaging [MeSH]
lokal Pituitary Neoplasms/pathology [MeSH]
lokal MRI
lokal Imaging
lokal Male [MeSH]
lokal Germ cell tumor
lokal Child [MeSH]
lokal Diabetes insipidus
lokal Child
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Posterior pituitary bright spot loss
lokal Pituitary gland
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Neoplasms, Germ Cell and Embryonal/pathology [MeSH]
lokal Hypothalamo-Hypophyseal System/diagnostic imaging [MeSH]
lokal Retrospective Studies [MeSH]
lokal Neoplasms, Germ Cell and Embryonal/diagnostic imaging [MeSH]
lokal Magnetic Resonance Imaging/methods [MeSH]
lokal Paediatric Neuroradiology
lokal Pituitary Gland, Posterior/pathology [MeSH]
lokal Pediatric
lokal Child, Preschool [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-0148-4652|https://orcid.org/0000-0002-7893-7982|https://orcid.org/0000-0001-6536-3898|https://orcid.org/0009-0007-5863-9578|https://orcid.org/0000-0003-0763-6506|https://orcid.org/0000-0001-5849-8671|https://orcid.org/0000-0003-1295-2685|https://orcid.org/0000-0002-3544-319X
1000 Hinweis
  • DeepGreen-ID: b5cde18341824f56b7fca1d185919f10 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Würzburg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Würzburg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6501216.rdf
1000 Erstellt am 2025-02-05T13:05:19.901+0100
1000 Erstellt von 322
1000 beschreibt frl:6501216
1000 Zuletzt bearbeitet 2025-07-30T11:38:10.763+0200
1000 Objekt bearb. Wed Jul 30 11:38:10 CEST 2025
1000 Vgl. frl:6501216
1000 Oai Id
  1. oai:frl.publisso.de:frl:6501216 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source